Joo-Hyun Lee

Joo-Hyun Lee

Auto-generated profile, based on publicly available information

Joo-Hyun Lee

Division of Rheumatology, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2021 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
HKHyeon-Kyoung Koo
Hyeon-Kyoung Koo
PSPamela Song
Pamela Song
JLJoo-Hyun Lee
Joo-Hyun Lee
Background: Asthma and osteoarthritis (OA) are medical conditions that inhibit physical activity and adversely affect quality of life. Despite the high prevalence, there are limited studies focusing on the comorbid condition and association between asthma and OA. The aim of this study was to assess the prevalence of OA co-occurring with asthma and to identify the relevant clinical considerations. Methods: Adult participants aged over 40 years who completed questionnaire assessments and spirometry tests were enrolled from the Korean National Health and Nutrition Examination Survey. Asthma and OA were defined based on the medical history of a diagnosis made by a doctor. Radiographic severities of OA were measured using the Kellgren–Lawrence grading system. Chronic obstructive pulmonary disease (COPD), as a comparative respiratory disease, was diagnosed based on the spirometric results. Results: A total of 9344 subjects were enrolled, and the prevalence of asthma and COPD were 4.6% ± 0.3% and 12.0% ± 0.5%, respectively. The prevalence of OA in the asthma group was 31.9% ± 2.8%, which was significantly higher than that in the COPD (17.8% ± 1.5%) or control (16.2% ± 0.6%) groups. OA was more prevalent in patients with asthma after adjusting for age, sex, body mass index, and smoking status (OR 1.65; 95% CI 1.27–2.13). Furthermore, after adjustment of this model for the prescription of OA medication, OA remained independently associated with asthma (OR 1.56; 95% CI 1.10–2.20). Conversely, the relationship of OA medication with asthma was not significant (P = 0.64). This relationship was evident in patients with asthma without airflow limitation measured by spirometry (OR 1.97; 95% CI 1.32–2.93). Moreover, the radiographic severity of knee OA correlated with asthma (OR 1.10; 95% CI 1.0–‍‍1.21). Conclusions: OA shows a high prevalence in patients with asthma, higher than in patients with COPD or the controls. The comorbid characteristics of these two conditions need to be considered in clinical practice.

SLSeung Yun Lee
Seung Yun Lee
WPWon Park
Won Park
YSYoung Ju Suh
Young Ju Suh
MLMie Jin Lim
Mie Jin Lim
SKSeong-Ryul Kwon
Seong-Ryul Kwon
KJKyong-Hee Jung
Kyong-Hee Jung
As the prevalence of gout and hyperuricemia increases, the comorbidities of gout and hyperuricemia have become a public health burden. In particular, risks of cardiovascular disease (CVD)-related complications are increasing. However, a few guidelines exist for the management of hyperuricemia. This cross-sectional study aimed to investigate the association of serum uric acid with CVD risk in the general population of Korean adults. We examined cross-sectional data from the first and second years of the seventh Korea National Health and Nutrition Examination Survey 2016–2017. Among 16,277 participants, 8781 were analyzed. We estimated the CVD risk using a 10-year CVD risk score prediction formula. There was a significant association of serum uric acid with 10-year CVD risk scores after adjusting for physical activity, body mass index, serum creatinine, and alcohol consumption in both sexes (p < 0.001). In the fitted fractional polynomial model, an approximate U-shaped association between serum uric acid levels and 10-year CVD risk scores was found in men. At the serum uric acid level of 6.9 mg/dL, the CVD risk was lowest. An approximate J-shaped association between serum uric acid levels and 10-year CVD risk scores was found in women. Our study showed that hyperuricemia was associated with an increased CVD risk. Hypouricemia was also associated with an increased CVD risk in men. We, therefore, recommend proper management of uric acid levels in the general population to reduce CVD risks.

1 January 2015 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HCHyo Jin Choi
Hyo Jin Choi
CLChan Hee Lee
Chan Hee Lee
JLJoo Hyun Lee
Joo Hyun Lee
BYBo Young Yoon
Bo Young Yoon
HKHyoun-Ah Kim
Hyoun-Ah Kim
HBHan Joo Baek
Han Joo Baek
Choi HJ, et al. J Korean Med Sci. 2015 Mar;30(3):240-244. http://dx.doi.org/10.3346/jkms.2015.30.3.240

1 January 2015 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KLKwang-Hoon Lee
Kwang-Hoon Lee
SCSang Tae Choi
Sang Tae Choi
SLSoo-Kyung Lee
Soo-Kyung Lee
JLJoo-Hyun Lee
Joo-Hyun Lee
BYBo-Young Yoon
Bo-Young Yoon
Lee KH, et al. J Korean Med Sci. 2015 Jun;30(6):700-704. https://doi.org/10.3346/jkms.2015.30.6.700

1 June 2020 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
YSYu Bin Seo
Yu Bin Seo
SMSu-Jin Moon
Su-Jin Moon
CJChan Hong Jeon
Chan Hong Jeon
JSJoon Young Song
Joon Young Song
YSYoon-Kyoung Sung
Yoon-Kyoung Sung
SLShin-Seok Lee
Shin-Seok Lee
To develop a clinical practice guideline for vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD), the Korean College of Rheumatology and the Korean Society of Infectious Diseases developed a clinical practice guideline according to the clinical practice guideline development manual. Since vaccination is unlikely to cause AIIRD or worsen disease activities, required vaccinations are recommended. Once patients are diagnosed with AIIRD, treatment strategies should be established and, at the same time, monitor their vaccination history. It is recommended to administer vaccines when the disease enters the stabilized stage. Administering live attenuated vaccines in patients with AIIRD who are taking immunosuppressants should be avoided. Vaccination should be considered in patients with AIIRD, prior to initiating immunosuppressants. It is recommended to administer influenza, Streptococcus pneumoniae, hepatitis A, hepatitis B, herpes zoster, measles-mumps-rubella virus, human papillomavirus, and tetanus-diphtheria-pertussis vaccines in patients with AIIRD; such patients who planned to travel are generally recommended to be vaccinated at the recommended vaccine level of healthy adults. Those who live in a household with patients with AIIRD and their caregivers should also be vaccinated at levels that are generally recommended for healthy adults.

1 January 2014 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SCSoo-Kyung Cho
Soo-Kyung Cho
JLJoo-Hyun Lee
Joo-Hyun Lee
MHMINKYUNG HAN
MINKYUNG HAN
SLSeunghun Lee
Seunghun Lee
JKJi Young Kim
Ji Young Kim
YSYoon-Kyoung Sung
Yoon-Kyoung Sung
Cho SK, et al. J Korean Med Sci. 2014 Jun;29(6):859-863. https://doi.org/10.3346/jkms.2014.29.6.859